Loading...
KSI-301: antibody biopolymer conjugate in retinal disorders
KSI-301 is a new intravitreal anti-vascular endothelial growth factor (VEGF) antibody biopolymer conjugate under investigation for the treatment of age-related macular degeneration (AMD), diabetic macular oedema (DME) and retinal vein occlusion (RVO). Preclinical and early clinical trials so far hav...
Na minha lista:
| Udgivet i: | Ther Adv Ophthalmol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278447/ https://ncbi.nlm.nih.gov/pubmed/34291186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/25158414211027708 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|